Stay updated with breaking news from Otonomy Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock analysts at StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Otonomy Price Performance NASDAQ:OTIC opened at $0.11 on Thursday. The business has a 50 day moving average of $0.11 and a […]
/PRNewswire/ -- Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, announced today the...
Otonomy Inc (OTIC) is expected to report $-0.47 for 4Q. Party City Holdco Inc (PRTYQ) is expected to report $-0.02 for 4Q. Pear Therapeutics Inc (PEAR) is expected to report for 4Q. Pieris Pharmaceuticals Inc (PIRS) is expected to report $-... | 06:22am
StockNews.com assumed coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note released on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Otonomy Price Performance NASDAQ OTIC opened at $0.11 on Wednesday. The firm has a market cap of $7.61 million, a P/E ratio of -0.14 and a […]
Otonomy (NASDAQ:OTIC – Get Rating) will announce its earnings results on Friday, March 24th. Otonomy Trading Up 0.7 % OTIC stock traded up $0.00 on Thursday, hitting $0.11. The company had a trading volume of 469,492 shares, compared to its average volume of 1,032,930. Otonomy has a 12-month low of $0.06 and a 12-month high […]